Lee says that with sufficient inventory (currently enough for 18 % of Taiwan's population, with plans to increase to 30 %), early administration of the drug may be safer, but if the drug is in short supply or there are concerns of drug resistance (due to those who don't complete the five-day course of the drug), then other measures need to be considered.
李秉穎指出，在庫存量足夠（目前為全國總人口數的 18 %，計畫增購至 30 %）的情況下，及早用藥或許比較保險，但如果藥量不夠或擔憂出現抗藥性（因未服完「全療程」5 天的藥量），則又有另外的考量。